封面
市場調查報告書
商品編碼
1455680

精準腫瘤市場,按產品類型、按適應症類型、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Precision Oncology Market, By Product Type, By Indication Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 323 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年精準腫瘤市場規模為695.8467億美元,2024年至2032年複合CAGR為11.2%。

精準腫瘤市場-市場動態

技術進步推動市場需求

市場成長的主要驅動力包括技術進步、對提供有效臨床結果的診斷產品不斷成長的需求,最大限度地減少治療副作用並防止抗藥性。同樣,不斷擴大的研究活動、乳癌的早期檢測以及患者的整體預後都將增強對精準腫瘤學的需求。由於全球範圍內的社交距離措施和封鎖,COVID-19 大流行已經影響了精準腫瘤學市場。此外,在大流行初期,臨床試驗研究暫時停止。然而,大流行後,醫院和診所進行精準腫瘤學分析和治療的患者流量下降。使用精準腫瘤學的延遲診斷和治療嚴重影響了癌症患者的照護。

精準腫瘤學市場 - 關鍵見解

根據研究分析師的分析,預計全球市場在預測期內(2024-2032年)每年將以 11.2%左右的CAGR成長

根據產品類型細分,預計治療藥物將在2023年顯示最大的市場佔有率

根據適應症類型細分,乳癌是2023年的主要類型

依地區分類,北美是2023年的主要收入來源

精準腫瘤學市場-細分分析:

全球精準腫瘤學市場根據產品類型、適應症類型、最終用途和地區進行細分。

根據產品類型,市場分為兩類:診斷和治療。2023年,在腫瘤不可知治療的批准數量不斷增加以及針對驅動癌症生長的特定蛋白質或突變的治療的獨特特徵等因素的推動下,治療領域成為市場領導者。基於精準腫瘤學的治療根據個別患者癌症的 DNA 指紋提供針對患者的特定癌症治療。

依適應症類型將市場分為六類:乳癌、大腸癌、子宮頸癌、肺癌、攝護腺癌等。2023年,由於人們越來越關注乳癌篩檢、診斷以及手術和放射技術的進步,乳癌佔據了最大的市場佔有率。此外,擴大研究工作、乳癌的早期檢測和改善患者預後預計將推動精準腫瘤學等新方法的發展。此外,先進的 DNA 定序技術的出現迅速推進了乳癌患者的治療。

精準腫瘤學市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

精準腫瘤學市場-競爭格局:

在市場上,專門從事精準腫瘤學的公司致力於創新診斷工具、分子分析技術和標靶治療,以最佳化癌症治療結果。他們將資源分配給研究和開發工作,目的是識別與不同癌症類型相關的生物標記和基因突變,實現更準確的診斷和治療選擇。此外,這些公司可以向醫療保健提供者提供全面的基因組分析服務,使他們能夠根據患者腫瘤的分子特徵做出明智的治療決策。此外,行銷活動目的是提高腫瘤學家、醫療保健提供者和患者對精準腫瘤學在提高治療效果、最大限度地減少不良反應並最終改善患者預後方面的好處的認知。精準腫瘤學領域的市場參與者採取各種創新策略,例如協議、新產品發布和擴張,以增強其市場佔有率。

最近的發展:

2021年 12月,ConcertAI, LLC 與 LabCorp 宣布合作,目的是加強精準腫瘤學研究。這些公司合作進行臨床研究,以減輕醫生實踐的負擔並提高患者保留率,確保公平地獲得研究作為護理選擇並推動患者招募。

目錄

第1章 精準腫瘤學市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依產品類型分類的精準腫瘤學市場摘要
    • 按適應症類型分類的精準腫瘤學市場摘要
    • 依最終用途分類的精準腫瘤學市場摘要
    • 依國家分類的精準腫瘤學市場摘要
    • 依地區分類的精準腫瘤學市場摘要
  • 競爭洞察

第3章 精準腫瘤學主要市場趨勢

  • 精準腫瘤學市場促進因素
    • 市場促進因素的影響分析
  • 精準腫瘤學市場限制
    • 市場限制影響分析
  • 精準腫瘤學市場機會
  • 精準腫瘤市場未來趨勢

第4章 精準腫瘤學產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 精準腫瘤學市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 精準腫瘤學市場格局

  • 2023年精準腫瘤學市佔分析
  • 按主要製造商分類的故障資料
    • 既有參與者分析
    • 新興參與者分析

第7章 精準腫瘤學市場 - 依產品類型

  • 概述
    • 依產品類型分類的細分市場佔有率分析
    • 診斷
    • 療法

第8章 精準腫瘤學市場 - 按適應症類型

  • 概述
    • 按指標類型分類的細分市場佔有率分析
    • 乳癌
    • 大腸直腸癌
    • 子宮頸癌
    • 攝護腺癌
    • 肺癌
    • 其他

第9章 精準腫瘤學市場 - 依最終用途

  • 概述
    • 依最終用途分類的細分市場佔有率分析
    • 醫院和診斷實驗室
    • 製藥與生物技術公司
    • 醫療保健資料公司

第10章 精準腫瘤學市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美精準腫瘤學主要製造商
    • 北美市場規模和預測(依國家)
    • 北美市場規模和預測(依產品類型)
    • 北美市場規模與預測(按適應症類型)
    • 北美市場規模和預測(依最終用途)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲精準腫瘤學主要製造商
    • 歐洲市場規模和預測(依國家)
    • 歐洲市場規模和預測(依產品類型)
    • 歐洲市場規模和預測(按指示類型)
    • 歐洲市場規模和預測(依最終用途)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區(APAC)
    • 概述
    • 亞太地區精準腫瘤主要製造商
    • 亞太地區市場規模與預測(依國家)
    • 亞太地區市場規模與預測(依產品類型)
    • 亞太地區市場規模與預測(依適應症類型)
    • 亞太地區市場規模和預測(依最終用途)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲精準腫瘤學主要製造商
    • 拉丁美洲市場規模與預測(依國家)
    • 拉丁美洲市場規模與預測(依產品類型)
    • 拉丁美洲市場規模與預測(按適應症類型)
    • 拉丁美洲市場規模和預測(依最終用途)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲精準腫瘤主要製造商
    • 中東和非洲市場規模及預測(依國家)
    • 中東和非洲市場規模及預測(依產品類型)
    • 中東和非洲市場規模及預測(按適應症類型)
    • 中東和非洲市場規模和預測(依最終用途)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第11章 關鍵供應商分析 - 精準腫瘤學產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Invitae Corporation
    • Qiagen NV
    • Illumina, Inc.
    • Laboratory Corporation Of America Holding
    • Exact Sciences Corporation
    • Rain Oncology Inc.
    • Strata Oncology, Inc.
    • Xilis, Inc.
    • Variantyx, Inc.
    • Bioserve
    • Relay Therapeutics
    • Acrivon Therapeutics
    • Others

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2343

REPORT HIGHLIGHT

Precision Oncology Market size was valued at USD 69,584.67 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Precision oncology, also referred to as personalized or targeted cancer therapy, represents a tailored approach to cancer treatment, wherein medical interventions such as medications and treatment plans are customized to match the individual characteristics of each patient and their specific cancer subtype. This method considers various factors including the tumor's genetic makeup, molecular profile, and the patient's overall health, aiming to pinpoint the most effective treatment options with minimal side effects.

Precision Oncology Market- Market Dynamics

Technological advancements to propel market demand

Key drivers of market growth include technological advancements, a growing demand for diagnostic products delivering effective clinical results, thereby minimizing therapeutic side effects and preventing drug resistance. Similarly, expanding research activities, early detection of breast cancer, and overall patient prognosis are poised to bolster the demand for precision oncology. The COVID-19 pandemic has impacted the precision oncology market due to social distancing measures and lockdowns worldwide. Additionally, clinical trial studies were temporarily halted during the initial phase of the pandemic. However, post-pandemic, hospitals and clinics have experienced a decline in patient flow for precision oncology analysis along with therapeutic treatment. Delayed diagnosis and treatment using precision oncology have significantly affected cancer patient care.

Precision Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Product Type segmentation, therapeutics was predicted to show maximum market share in the year 2023

Based on Indication Type segmentation, breast cancer was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Oncology Market- Segmentation Analysis:

The Global Precision Oncology Market is segmented on the basis of Product Type, Indication Type, End Use, and Region.

The market is divided into two categories based on Product Type: diagnostics and therapeutics. In 2023, the therapeutics segment emerged as the market leader, propelled by factors such as the increasing amount of approvals for tumor-agnostic treatments and the unique characteristics of therapeutics tailored to specific proteins or mutations driving cancer growth. Precision oncology-based treatments offer patient-specific cancer treatment based on the DNA fingerprint of individually patient's cancer.

The market is divided into six categories based on Indication Type: breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and others. In 2023, breast cancer held the largest market share, attributed to the growing focus on breast cancer screening, diagnosis, and advancements in surgical and radiation techniques. Additionally, expanding research endeavors, early detection of breast cancer, and improved patient prognosis are expected to drive the development of novel methods like precision oncology. Furthermore, the advent of advanced technologies for DNA sequencing has rapidly advanced the treatment of breast cancer patients.

Precision Oncology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Precision Oncology Market- Competitive Landscape:

In the marketplace, companies specializing in precision oncology concentrate on innovating diagnostic tools, molecular profiling technologies, and targeted therapies to optimize cancer treatment outcomes. They allocate resources to research and development endeavors aimed at identifying biomarkers and genetic mutations associated with different cancer types, enabling more accurate diagnosis and treatment selection. Additionally, these companies may provide comprehensive genomic profiling services to healthcare providers, empowering them to make informed treatment decisions based on the molecular characteristics of the patient's tumor. Moreover, marketing initiatives seek to raise awareness among oncologists, healthcare providers, and patients regarding the benefits of precision oncology in enhancing treatment efficacy, minimizing adverse effects, and ultimately improving patient outcomes. Market players in the precision oncology sector are engaging in various innovative strategies such as agreements, new product launches, and expansions to bolster their market presence.

Recent Developments:

In December 2021, ConcertAI, LLC, along with LabCorp declared a collaboration aimed at enhancing precision oncology research. These companies are collaborating to launch clinical studies that will alleviate the burden on physician practices and improve patient retention, thereby ensuring equitable access to research as a care option and driving patient recruitment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Invitae Corporation

Qiagen N.V.

Illumina, Inc.

Laboratory Corporation Of America Holding

Exact Sciences Corporation

Rain Oncology Inc.

Strata Oncology, Inc.

Xilis, Inc.

Variantyx, Inc.

Bioserve

Relay Therapeutics

Acrivon Therapeutics

Others

GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutics

GLOBAL PRECISION ONCOLOGY MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Lung Cancer
  • Others

GLOBAL PRECISION ONCOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Data Companies

GLOBAL PRECISION ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Precision Oncology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Precision Oncology Market Snippet by Product Type
    • 2.1.2.Precision Oncology Market Snippet by Indication Type
    • 2.1.3.Precision Oncology Market Snippet by End-Use
    • 2.1.4.Precision Oncology Market Snippet by Country
    • 2.1.5.Precision Oncology Market Snippet by Region
  • 2.2.Competitive Insights

3.Precision Oncology Key Market Trends

  • 3.1.Precision Oncology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Precision Oncology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Precision Oncology Market Opportunities
  • 3.4.Precision Oncology Market Future Trends

4.Precision Oncology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Precision Oncology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Precision Oncology Market Landscape

  • 6.1.Precision Oncology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Precision Oncology Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Diagnostics
    • 7.1.3.Therapeutics

8.Precision Oncology Market - By Indication Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2.Breast Cancer
    • 8.1.3.Colorectal Cancer
    • 8.1.4.Cervical Cancer
    • 8.1.5.Prostate Cancer
    • 8.1.6.Lung Cancer
    • 8.1.7.Others

9.Precision Oncology Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals & Diagnostic Laboratories
    • 9.1.3.Pharmaceutical & Biotechnology Companies
    • 9.1.4.Healthcare Data Companies

10.Precision Oncology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Precision Oncology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Precision Oncology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Precision Oncology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Precision Oncology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Precision Oncology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Oncology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Thermo Fisher Scientific Inc.
    • 11.2.2.Invitae Corporation
    • 11.2.3.Qiagen N.V.
    • 11.2.4.Illumina, Inc.
    • 11.2.5.Laboratory Corporation Of America Holding
    • 11.2.6.Exact Sciences Corporation
    • 11.2.7.Rain Oncology Inc.
    • 11.2.8.Strata Oncology, Inc.
    • 11.2.9.Xilis, Inc.
    • 11.2.10.Variantyx, Inc.
    • 11.2.11.Bioserve
    • 11.2.12.Relay Therapeutics
    • 11.2.13.Acrivon Therapeutics
    • 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Precision Oncology Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Precision Oncology Market, by Product Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Precision Oncology Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: End-Use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Precision Oncology Market, by End-Use 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Precision Oncology Market, by Region 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • FIGURE Precision Oncology Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication Type segment market share analysis, 2023 & 2032
  • FIGURE Indication Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-Use segment market share analysis, 2023 & 2032
  • FIGURE End-Use segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Precision Oncology Market share and leading players, 2023
  • FIGURE Europe Precision Oncology Market share and leading players, 2023
  • FIGURE Asia Pacific Precision Oncology Market share and leading players, 2023
  • FIGURE Latin America Precision Oncology Market share and leading players, 2023
  • FIGURE Middle East and Africa Precision Oncology Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Precision Oncology Market share analysis by country, 2023
  • FIGURE Germany Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Precision Oncology Market share analysis by country, 2023
  • FIGURE India Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market share analysis by country, 2023
  • FIGURE Brazil Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market share analysis by country, 2023
  • FIGURE Saudi Arabia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)